<--- Back to Details
First PageDocument Content
Ammine complexes / Eli Lilly and Company / Extravasation / Cisplatin / Vinorelbine / Vinca alkaloid / Methadone / Lung cancer / Metastatic breast cancer / Chemistry / Alkaloids / Alkylating antineoplastic agents
Date: 2004-01-13 09:40:20
Ammine complexes
Eli Lilly and Company
Extravasation
Cisplatin
Vinorelbine
Vinca alkaloid
Methadone
Lung cancer
Metastatic breast cancer
Chemistry
Alkaloids
Alkylating antineoplastic agents

NAVELBINE® PRESCRIBING INFORMATION (vinorelbine tartrate) Injection

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 291,05 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at

DocID: 1trwM - View Document

Medicine / Health / Clinical medicine / Ribbon symbolism / RTT / Breast cancer / Metastatic breast cancer / Oncology / Bone metastasis / Radiation therapy / Brain metastasis / Metastatic liver disease

· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract

DocID: 1rmV3 - View Document

Medicine / Clinical medicine / Transplantation medicine / Graft-versus-host disease / Hematopoietic stem cell transplantation / Breast cancer / Treatment of cancer / Chemotherapy / Metastatic breast cancer / Graft versus tumor effect / Cell therapy / Lumpectomy

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

DocID: 1riiF - View Document

Health / Medicine / Clinical medicine / Ribbon symbolism / RTT / Breast cancer / Metastatic breast cancer / CCL2 / Friedrich Miescher Institute for Biomedical Research / Metastasis / Tumor microenvironment / Angiogenesis

Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

DocID: 1rf3r - View Document